pI: 9.362 |
Length (AA): 1024 |
MW (Da): 111767 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 11 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
6 | 345 | 3uto (A) | 51 | 417 | 28.00 | 0 | 1 | 0.591431 | 0.22 |
19 | 340 | 3i6u (A) | 154 | 487 | 34.00 | 0 | 1 | 0.645353 | -0.03 |
26 | 392 | 5uvc (A) | 106 | 531 | 25.00 | 0 | 1 | 0.498498 | 0.14 |
35 | 340 | 4yhj (A) | 134 | 450 | 26.00 | 0 | 1 | 0.581728 | -0.15 |
37 | 362 | 4ejn (A) | 63 | 435 | 34.00 | 0 | 1 | 0.602259 | 0.04 |
83 | 447 | 6c9d (A) | 56 | 736 | 52.00 | 0 | 1 | 1.01085 | -0.53 |
83 | 397 | 2r0i (A) | 49 | 361 | 56.00 | 0 | 1 | 0.848717 | -0.43 |
83 | 351 | 3mn3 (A) | 51 | 317 | 48.00 | 0 | 1 | 0.773595 | -0.43 |
84 | 512 | 4rer (A) | 15 | 535 | 30.00 | 0 | 1 | 0.592045 | 0.64 |
87 | 360 | 4fgb (A) | 20 | 298 | 35.00 | 0 | 1 | 0.706478 | -0.81 |
889 | 1024 | 3ose (A) | 696 | 795 | 42.00 | 0.00000000023 | 0.98 | 0.283213 | -0.11 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_245942)
Species | Accession | Gene Product |
---|---|---|
Echinococcus granulosus | EgrG_001156900 | serine threonine protein kinase sik |
Schistosoma japonicum | Sjp_0068350 | U6 snRNA-associated Sm-like protein LSm7, putative |
Schistosoma japonicum | Sjp_0068380 | Serine/threonine-protein kinase MARK2, putative |
Schistosoma mansoni | Smp_014170.2 | serine/threonine protein kinase |
Schistosoma mansoni | Smp_014170.1 | serine/threonine protein kinase |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Oryctolagus cuniculus | Cyclin-dependent kinase 4 | 189 aa | 33.5% | 170 aa | Compounds | References |
Rattus norvegicus | Mitogen-activated protein kinase 8 | 411 aa | 26.5% | 355 aa | Compounds | References |
Rattus norvegicus | Mitogen-activated protein kinase 1 | 358 aa | 26.9% | 353 aa | Compounds | References |
Rattus norvegicus | Serine/threonine-protein kinase pim-3 | 326 aa | 30.7% | 264 aa | Compounds | References |
Rattus norvegicus | MAP kinase p38 alpha | 360 aa | 26.8% | 340 aa | Compounds | References |
Sus scrofa | Casein kinase I isoform alpha | 125 aa | 25.0% | 128 aa | Compounds | References |